What is SMC International?

SMC International connects international patients with 50+ expert doctors across 8 crucial wellness and investment pages, simplifying global healthcare access.

Is NeuroEPO approved by the FDA?

No. NeuroEPO is not FDA-approved and is not available in the United States. It is used within research protocols at Cuban neuroscience institutions. American patients should understand that NeuroEPO is investigational — it is not a cure, and individual outcomes vary. It is offered as part of a comprehensive program including intensive rehabilitation, not as a standalone treatment.

How does Cuba's approach compare to lecanemab (Leqembi) or donanemab (Kisunla)?

Lecanemab and donanemab are FDA-approved anti-amyloid drugs for mild Alzheimer's that target amyloid plaques. They cost $26,000–$32,000+/year and carry ARIA risks. Cuba's approach is different — it focuses on intensive cognitive rehabilitation (4–6 hours daily), neuroprotective research with NeuroEPO, pharmacological management, and caregiver education. The approaches are not mutually exclusive; some patients may benefit from both.

Does U.S. health insurance or Medicare cover treatment in Cuba?

No. Medicare, Medicaid, and U.S. private health insurance typically do not cover treatment in Cuba. Patients are responsible for the full cost. However, HSA/FSA funds may be usable — consult your plan administrator. Medical expenses may also be tax-deductible if they exceed 7.5% of adjusted gross income.

What is the Alzheimer's caregiver support program in Cuba?

Caregiver education is a mandatory, core component of the Cuban Alzheimer's program at CIREN. Caregivers receive hands-on training in cognitive stimulation, daily routine management, communication strategies, behavioral management, safety, and self-care. A comprehensive written guide is provided for ongoing reference at home.

How long is the Alzheimer's treatment program in Cuba?

Intensive programs typically last 4–8 weeks, depending on the patient's cognitive stage, overall health, and treatment goals. The duration is determined by the multidisciplinary medical team following the initial evaluation. Longer programs may be recommended for more advanced cases.

For New York Families

Alzheimer's Clinical Evaluation

Alzheimer's Evaluation in Cuba for New York Families

Cuba's Alzheimer's evaluation program provides a comprehensive, multidisciplinary clinical assessment — neuropsychological testing, brain MRI review, blood work, and a full-day multidisciplinary team evaluation. For American families seeking an independent, in-depth assessment of their loved one's cognitive condition. New York has approximately 410,000 residents with Alzheimer's. New York's large aging population and high cost of memory care make Cuba's intensive rehabilitation program a compelling alternative. JFK and Newark offer connecting flights, and Buffalo families can access Roswell Park's CIMAvax trials — but NeuroEPO and CIREN's intensive cognitive rehabilitation are available only in Cuba.

Request Medical Evaluation Upload Medical Records

Alzheimer's Evaluation in Cuba in Cuba for New York patients

410K

New York residents with Alzheimer's

17%

population aged 65+

3–4 hours (direct charter or via Miami)

to Havana

Direct

flights available

What the Alzheimer's Evaluation Includes

A comprehensive evaluation is the foundation of Cuba's Alzheimer's program. Without an accurate understanding of the patient's cognitive stage, type of dementia, and overall health, no treatment plan can be effective. Cuba's evaluation is more comprehensive than what most U.S. patients receive in a standard neurology appointment.

The evaluation includes: neuropsychological testing (a detailed assessment of memory, attention, language, executive function, and visuospatial skills), brain MRI review (to assess brain atrophy, vascular changes, and rule out other causes), comprehensive blood work (to rule out reversible causes of cognitive decline and assess overall health), and a multidisciplinary team assessment (neurologist, neuropsychologist, rehabilitation specialist, and internist).

Following the evaluation, the medical team provides a comprehensive report with the diagnosis, cognitive stage, treatment recommendations, and a personalized rehabilitation plan. This report is shared with the patient's U.S. neurologist for coordinated care. The evaluation is particularly valuable for patients with uncertain diagnoses, early-stage cognitive decline, or those seeking a second opinion before committing to a full treatment program.

No treatment currently cures Alzheimer's disease. Cuba's program aims to slow cognitive decline, maintain function, and improve quality of life. NeuroEPO is investigational and not FDA-approved. Treatment suitability is determined after individual medical evaluation. Individual outcomes vary.

Travel from New York to Cuba

Getting to Havana from New York

New York's large aging population and high cost of memory care make Cuba's intensive rehabilitation program a compelling alternative. JFK and Newark offer connecting flights, and Buffalo families can access Roswell Park's CIMAvax trials — but NeuroEPO and CIREN's intensive cognitive rehabilitation are available only in Cuba.

Departure Airports

JFK (New York)
Newark (EWR)
Buffalo (BUF)
Albany (ALB)

Travel time: 3–4 hours (direct charter or via Miami)

Travel Authorization

• U.S. citizens can travel to Cuba under approved categories
• SMC Salud provides letter of medical necessity
• Treatment confirmation documentation included
• Airport reception and ground transport in Havana
• English-speaking coordinators throughout your stay

Serving families across New York:

New York CityBuffaloRochesterYonkersSyracuseAlbanyBronxBrooklyn

More Alzheimer's & Dementia Topics

Related Alzheimer's & Dementia Treatment Options

Alzheimer's Treatment in Cuba in New York

Alzheimer's treatment in Cuba for American patients — NeuroEPO neuroprotective research, intensive cognitive rehabilitation at CIREN, and comprehensive clinical evaluation. Travel authorization, HSA/FSA, English coordinators.

Learn more

Alzheimer's Rehabilitation in Cuba in New York

Alzheimer's rehabilitation in Cuba — 4–6 hours of daily multidisciplinary therapy at CIREN for American patients. Cognitive rehabilitation, neuropsychology, occupational therapy, and physical therapy in an intensive 4–8 week program.

Learn more

Alzheimer's Second Opinion from Cuba in New York

Seek a second opinion for Alzheimer's from Cuba's neurology team — independent review of neuropsychological testing, MRI, and medical history. For American families exploring treatment options beyond domestic care.

Learn more

Cognitive Rehabilitation in Cuba in New York

Cognitive rehabilitation for Alzheimer's in Cuba — intensive daily therapy at CIREN targeting memory, attention, language, and executive function. 4–6 hours per day for 4–8 weeks for U.S. patients.

Learn more

Dementia Rehabilitation in Cuba in New York

Dementia rehabilitation in Cuba for U.S. patients — intensive multidisciplinary therapy at CIREN for Alzheimer's, vascular dementia, Lewy body dementia, and frontotemporal dementia. 4–6 hours daily for 4–8 weeks.

Learn more

Alzheimer's International Patient Program in New York

Alzheimer's international patient program in Cuba — medical review, travel coordination, intensive treatment, caregiver training, accommodation, and telemedicine follow-up. Full-service program for American families.

Learn more

Alzheimer's Care for U.S. Patients in New York

Alzheimer's care in Cuba designed for American patients — English coordinators, travel authorization support, HSA/FSA guidance, telemedicine follow-up, and coordination with U.S. neurologists.

Learn more

Alzheimer's Treatment Options in Cuba in New York

Complete guide to Alzheimer's treatment options in Cuba — NeuroEPO, intensive cognitive rehabilitation, pharmacological management, caregiver training, and comprehensive evaluation. For American families exploring options.

Learn more

Early Alzheimer's Evaluation in Cuba in New York

Early Alzheimer's evaluation in Cuba for American patients — early-stage cognitive assessment, mild cognitive impairment evaluation, and personalized treatment planning. Early diagnosis enables more treatment options.

Learn more

Available in Your State

Alzheimer's Evaluation in Cuba by U.S. State

Florida

580K

Texas

400K

California

720K

New York

410K

Pennsylvania

280K

Ohio

220K

Michigan

190K

Georgia

150K

North Carolina

180K

Illinois

230K

Louisiana

89K

Maryland

110K

Mississippi

57K

South Carolina

95K

Oklahoma

67K

Southeastern United States

1.1M

Southern United States

1.4M

Eastern United States

3.2M

East Coast

2.2M

Frequently Asked Questions

Questions from New York Families

Yes. U.S. citizens can travel to Cuba under approved categories. SMC Salud provides all necessary documentation, including the letter of medical necessity and treatment confirmation, to support travel authorization. Our team guides you through the entire process to ensure compliance with all regulations.

Ready to Explore Alzheimer's Evaluation in Cuba in Cuba?

Submit your medical records for a complimentary review. New York families receive a personalized treatment proposal within 5–10 business days.

Request Medical Evaluation Upload Medical Records WhatsApp Us